The Benchmark Company lifts AbCellera Biologics Inc [ABCL] price estimate. Who else is bullish?
AbCellera Biologics Inc [NASDAQ: ABCL] traded at a high on 2025-06-24, posting a 7938244 gain after which it closed the day’ session at $4910000.0. The results of the trading session contributed to over 7938244 shares changing hands. Over the past one week, the price volatility